Drug trial aims to stop breast cancer before it spreads
NCT ID NCT06613516
Summary
This study aimed to see if a drug called Capivasertib could help prevent breast cancer from coming back. It focused on women with a specific type of breast cancer who had finished their main treatment but had tiny traces of cancer DNA in their blood, which is an early warning sign the cancer might return. The plan was to give these women the drug for up to two years to see if it could clear this cancer DNA from their blood and stop the disease from spreading.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imperial College Healthcare Trust
London, United Kingdom
Conditions
Explore the condition pages connected to this study.